These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


107 related items for PubMed ID: 3882167

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Induction of T-cell producers of the macrophage migration inhibitory factor by the products of the K-, I- and D-regions of the H-2 complex in mice].
    Kharkevich DD, Suslov AP.
    Biull Eksp Biol Med; 1985 Apr; 99(4):484-6. PubMed ID: 3886043
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. T helper cells change their Lyt-1,2 phenotype during an immune response.
    Thomas DB, Calderon RA.
    Eur J Immunol; 1982 Jan; 12(1):16-23. PubMed ID: 6174347
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mouse alloantibodies capable of blocking cytotoxic T cell function. V. The majority of I region-specific CTL are Lyt-2+ but are relatively resistant to anti-Lyt-2 blocking.
    Shinohara N, Kojima M.
    J Immunol; 1984 Feb; 132(2):578-83. PubMed ID: 6197465
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Positively selected Lyt-2+ and Lyt-2- mouse T lymphocytes are comparable, after Con A stimulation, in release of IL 2 and of lymphokines acting on B cells, macrophages, and mast cells, but differ in interferon production.
    Guerne PA, Piguet PF, Vassalli P.
    J Immunol; 1983 May; 130(5):2225-30. PubMed ID: 6187845
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Release of a mitogenic factor by splenic Lyt 1+ T-cells from mice treated with SSM, an immunomodulator extracted from human type tubercle bacilli.
    Pollard RB, Schmitt DA, Sasaki H, Hayashi Y, Suzuki F.
    Anticancer Res; 1990 May; 10(2A):285-90. PubMed ID: 2346302
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Idiotype-specific inactivation by xenogeneic antisera of T killers but not of T-MIF producers immune to H-2 complex antigens].
    Egorova SG, Nesterenko VG, Suslov AP, Brondz BD.
    Biull Eksp Biol Med; 1983 Apr; 95(4):63-5. PubMed ID: 6338966
    [Abstract] [Full Text] [Related]

  • 20. Characterization of two different Ly-1+ T cell populations that mediate delayed-type hypersensitivity.
    Van Loveren H, Kato K, Meade R, Green DR, Horowitz M, Ptak W, Askenase PW.
    J Immunol; 1984 Nov; 133(5):2402-11. PubMed ID: 6332850
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.